Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

DGX holding history

Quest Diagnostics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DGX overviewAll 13F holders of DGXFull Q2 2026 holdings

Shares (Q2 2026)
4,814
Value
$1.02M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of DGX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,814$1.02M<0.1%−142,913−96.7%ReducedHolders
Q1 2026147,727$29.0M<0.1%−181,007−55.1%ReducedHolders
Q4 2025328,734$57.0M<0.1%+328,734NewHolders
Q1 20250$00.0%−79,369−100.0%Sold outHolders
Q4 202479,369$12.0M<0.1%+76,397+2,570.6%AddedHolders
Q3 20242,972$461.4K<0.1%−11,197−79.0%ReducedHolders
Q2 202414,169$1.94M<0.1%−94,502−87.0%ReducedHolders
Q1 2024108,671$14.5M<0.1%+47,849+78.7%AddedHolders
Q4 202360,822$8.39M<0.1%+38,347+170.6%AddedHolders
Q3 202322,475$2.74M<0.1%−48,344−68.3%ReducedHolders
Q2 202370,819$9.95M<0.1%−38,641−35.3%ReducedHolders
Q1 2023109,460$15.5M<0.1%+46,530+73.9%AddedHolders
Q4 202262,930$9.84M<0.1%+21,562+52.1%AddedHolders
Q3 202241,368$5.08M<0.1%−10,514−20.3%ReducedHolders
Q2 202251,882$6.90M<0.1%−15,318−22.8%ReducedHolders
Q1 202267,200$9.20M<0.1%−316,975−82.5%ReducedHolders
Q4 2021384,175$66.5M0.1%+197,774+106.1%AddedHolders
Q3 2021186,401$27.1M<0.1%−84,377−31.2%ReducedHolders
Q2 2021270,778$35.7M<0.1%−11,041−3.9%ReducedHolders
Q1 2021281,819$36.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.